To Homepage

Select your language

Die Inhalte dieser Seite sind auch auf Deutsch verfügbar.

Auf Deutsch ansehen
Contact Us We are here
to help you
Contact us for your next nucleic acid program! Contact us

BioSpring Gesellschaft für Biotechnologie mbH
Germany

Alt-Fechenheim 34
60386 Frankfurt am Main

This email address is being protected from spambots. You need JavaScript enabled to view it.
+49 69 6605500-0

BioSpring, Inc.
USA

888 Prospect Street, Suite 200
La Jolla, CA 92037

This email address is being protected from spambots. You need JavaScript enabled to view it.

Our US subsidiary supports our North American clients with their manufacturing and analytical requests for R&D and cGMP services, complementing our headquarters and cGMP manufacturing site in Germany.

BioSpring
Japan

1-2-2, Hitotsubashi, Chiyoda-ku, Tokyo 100-0003
Sumitomo Corporation Takebashi BLD. 12F

This email address is being protected from spambots. You need JavaScript enabled to view it.
+81-3-5220-1560

Our experienced and long-standing partner Summit Pharmaceuticals International provides local support to our clients in Japan.

Submit your inquiry

Your contact information

If not available please answer with non

Your question or request

(Multiple selections possible)
1. Manufacturing Services
(Multiple selections possible)
2. Oligonucleotide Modality
(please include a legend indicating chemistry type and any modifications / If sequence is not applicable, please indicate length, chemistry type, number of sequences, modifications)
(indication in nmol, mg, g)
(e.g., for Endotoxin measurement, Desalting, HPLC-purified, Aliquots etc.)
(Multiple selections possible)
1. Type of Service 1
(Multiple selections possible)
2. Type of Service 2
(Multiple selections possible)
3. Type of Service 3

By submitting the contact form, you consent to the processing of the data entered by you for the purposes of handling your inquiry. You may withdraw this consent at any time, effective for future processing. For more information, please see our Data Privacy Notice.